Asthma management: the principles

Key points

  • The goal is control: few symptoms and a minimal risk of attacks.
  • International guidance favors treatment that acts on airway inflammation rather than a bronchodilator alone.
  • A written action plan, inhaler technique and regular review are part of treatment itself.
  • No change to treatment should be made without advice from a doctor or pharmacist.

This page presents general principles. It gives no doses and no adjustment schedules: those decisions belong to a health professional who knows your situation.

Aim for control

The goal of treatment is good control, meaning symptom burden and the risk of exacerbations are kept as low as possible.1 Management works as a cycle: assess symptom control, risk factors, coexisting conditions, side effects and patient satisfaction, adjust treatment through shared decisions, then reassess.1 A recent review notes that most patients can reach good control but that under-treatment remains common, so patients and clinicians need to understand when and how treatment is adjusted.2

Treatment that acts on inflammation

Anti-inflammatory and bronchodilator treatments are the mainstay of asthma therapy.1 Inhalers differ in role: some open the airways and relieve symptoms, others reduce inflammation and the risk of severe attacks, and some combine both.3

Published summaries of the Global Initiative for Asthma (GINA) strategy point the same way. In its 2021 version, GINA recommends that adults and adolescents with asthma should not be treated with a short-acting bronchodilator alone, because of the risks of that approach and of overuse, and because inhaled corticosteroids are of proven benefit. The authors report that in large trials in mild asthma, a reliever combining an inhaled corticosteroid with formoterol, taken as needed, cut severe exacerbations by at least 60% compared with a short-acting bronchodilator alone.4 The 2022 primary-care summary states that all adults, adolescents and most children with asthma should receive treatment containing an inhaled corticosteroid.5 These documents are written for clinicians. They date from 2021 and 2022, and GINA publishes updates regularly.6 They do not entitle anyone to change their own treatment.

The written action plan

An action plan provided by a health professional helps people take greater control of their treatment, including when symptoms worsen.3 It may include monitoring, avoiding triggers and using medicines.7 A 2003 Cochrane review concluded that, in adults, self-management education that combines monitoring by symptoms or peak flow, regular medical review and a written action plan improves health outcomes.8 In children, a 2006 Cochrane review of four trials found fewer acute care visits with symptom-based plans than with peak flow plans.9 See also action plans for children and patient education.

Inhaler technique

Using an inhaler can be difficult, especially for children and in emergencies, and a spacer makes delivery easier.3 Education programs aim in particular to improve technique and the recognition of symptoms.10 Ask your pharmacist or doctor to check how you use your device. See inhalers.

Regular review

Regular personalized assessment, treatment of modifiable risk factors, self-management education, skills training and review remain essential at every age and level of severity.4 Measuring peak flow is one monitoring tool, as your clinician decides.

Reducing triggers

Avoiding triggers can help reduce symptoms,3 but studies of avoidance measures give mixed results.1112 See triggers. Avoidance complements prescribed treatment and never replaces it.

Severe asthma

Asthma is classed as severe when it needs high-intensity treatment to stay under control, or remains uncontrolled despite treatment, and biological therapies exist for some forms.1 Specialist review is then useful.

Children and adolescents

A consensus report from European and North American academies, dating from 2008, recommends for children a combination of drug treatment, allergen and trigger avoidance and asthma education.13 More recently, GINA's 2021 changes added new treatment options for children aged 6 to 11.4 Children depend on adults to notice problems and to supervise devices, which is why schools and carers are part of the plan. See talking with school.

When work is part of the picture, management of work-exacerbated asthma focuses on reducing exposures at work and optimizing standard medical care, with a change of job only if those measures fail.14 See work-exacerbated asthma.

Not one size fits all

The 2022 GINA primary-care summary stresses that asthma treatment is not "one size fits all" and recommends individualized assessment, adjustment and review.5 The principle behind each page of this section is the same: general information helps you prepare, and decisions about your care are made with the people who know you.

Sources

  1. Papi A, Brightling C, Pedersen SE, et al. Asthma. Lancet. 2018;391(10122):783-800. PubMed 29273246. DOI
  2. Porsbjerg C, Melén E, Lehtimäki L, et al. Asthma. Lancet. 2023;401(10379):858-873. PubMed 36682372. DOI
  3. World Health Organization. Asthma: fact sheet.
  4. Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. Am J Respir Crit Care Med. 2022;205(1):17-35. PubMed 34658302. DOI
  5. Levy ML, Bacharier LB, Bateman E, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023;33(1):7. PubMed 36754956. DOI
  6. GINA. Global Initiative for Asthma, Reports.
  7. National Heart, Lung, and Blood Institute. What Is Asthma?.
  8. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003(1):CD001117. PubMed 12535399. DOI
  9. Bhogal S, Zemek R, Ducharme FM. Written action plans for asthma in children. Cochrane Database Syst Rev. 2006(3):CD005306. PubMed 16856090. DOI
  10. Harris K, Kneale D, Lasserson TJ, et al. School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review. Cochrane Database Syst Rev. 2019;1(1):CD011651. PubMed 30687940. DOI
  11. Gøtzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev. 2008;2008(2):CD001187. PubMed 18425868. DOI
  12. Leas BF, D’Anci KE, Apter AJ, et al. Effectiveness of indoor allergen reduction in asthma management: A systematic review. J Allergy Clin Immunol. 2018;141(5):1854-1869. PubMed 29452202. DOI
  13. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 2008;63(1):5-34. PubMed 18053013. DOI
  14. Henneberger PK, Redlich CA, Callahan DB, et al. An official american thoracic society statement: work-exacerbated asthma. Am J Respir Crit Care Med. 2011;184(3):368-78. PubMed 21804122. DOI

AsmaNet publishes educational information that does not replace advice from a doctor or occupational health professional. If someone is struggling to breathe, call your local emergency number. This content has not been reviewed by a clinician.